FIP200 inhibits β-catenin-mediated transcription by promoting APC-independent β-catenin ubiquitination

Oncogene

Volumn 32, Issue 19, 2013, Pages 2421-2432

  Choi, J D ^a,b   Ryu, M ^a   Ae Park, M ^a,c   Jeong, G ^b   Lee, J S ^a  

^a Ajou University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

catenin; FIP200; ubiquitination

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; CELL PROTEIN; CELL PROTEIN FIP200; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEASOME; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; COLON POLYPOSIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; GENE EXPRESSION REGULATION; HCT116 CELLS; HEK293 CELLS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 84877627390     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.262     Document Type: Article

References (43)

1. Nusse R. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 2003; 130: 5297-5305.
2. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss-and gain-of-function mutations of beta-catenin in mice. Genes Dev 2008; 22: 2308-2341.
3. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320.
4. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of beta-catenin by human axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 1998 8573-8581.
5. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999; 9: 207-210.
6. Latres E, Chiaur DS, Pagano M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 1999; 18: 849-854.
7. Ha NC, Tonozuka T, Stamos JL, Choi HJ, Weis WI. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 2004; 15: 511-521.
8. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997; 275: 1784-1787.
9. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851.
10. Gan B, Guan JL. FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal 2008; 20: 787-794.
11. Ueda H, Abbi S, Zheng C, Guan JL. Suppression of Pyk2 kinase and cellular activities by FIP200. J Cell Biol 2000; 149: 423-430.
12. Abbi S, Ueda H, Zheng C, Cooper LA, Zhao J, Christopher R et al. Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 2002; 13: 3178-3191.
13. Gan B, Melkoumian ZK, Wu X, Guan KL, Guan JL. Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J Cell Biol 2005; 170: 379-389.
14. Gan B, Peng X, Nagy T, Alcaraz A, Gu H, Guan JL. Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J Cell Biol 2006; 175: 121-133.
15. Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, Saeki Y. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 2002; 21: 1295-1298.
16. Martin N, Schwamborn K, Urlaub H, Gan B, Guan JL, Dejean A. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity. Mol Cell Biol 2008; 28: 2771-2781.
17. Chano T, Ikegawa S, Saito-Ohara F, Inazawa J, Mabuchi A, Saeki Y et al. Isolation, characterization and mapping of the mouse and human RB1CC1 genes. Gene 2002; 291: 29-34.
18. Chano T, Kontani K, Teramoto K, Okabe H, Ikegawa S. Truncating mutations of RB1CC1 in human breast cancer. Nat Genet 2002; 31: 285-288.
19. Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 2005; 65: 6676-6684.
20. Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 2011; 25: 1510-1527.
21. Bae H, Guan JL. Suppression of autophagy by FIP200 deletion impairs DNA damage repair and increases cell death upon treatments with anticancer agents. Mol Cancer Res 2011; 9: 1232-1241.
22. Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 2008; 181: 497-510.
23. Koinuma D, Shinozaki M, Nagano Y, Ikushima H, Horiguchi K, Goto K et al. RB1CC1 positively regulates transforming growth factor-{beta} signaling through the modulation of Arkadia E3 ubiquitin ligase activity. J Biol Chem 2011; 286: 32502-32512.
24. Wood A, Garg P, Burgers PM. A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage. J Biol Chem 2007; 282: 20256-20263.
25. Sabbioneda S, Green CM, Bienko M, Kannouche P, Dikic I, Lehmann AR. Ubiquitin-binding motif of human DNA polymerase eta is required for correct localization. Proc Natl Acad Sci USA 2009; 106: E20; author reply E21.
26. Hofmann K. Ubiquitin-binding domains and their role in the DNA damage response. DNA Repair 2009; 8: 544-556.
27. Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T et al. Autophagy negatively regulates Wnt signalling by promoting dishevelled degradation. Nat Cell Biol 2010; 12: 781-790.
28. Sukhdeo K, Mani M, Hideshima T, Takada K, Pena-Cruz V, Mendez G et al. Beta-catenin is dynamically stored and cleared in multiple myeloma by the protea-some-aggresome-autophagosome-lysosome pathway. Leukemia 2011; 26: 1116-1119.
29. Ganley IG, Lam du H, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009; 284: 12297-12305.
30. Liang CC, Wang C, Peng X, Gan B, Guan JL. Neural-specific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration. J Biol Chem 2010; 285: 3499-3509.
31. Liu F, Lee JY, Wei H, Tanabe O, Engel JD, Morrison SJ et al. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 2010; 116: 4806-4814.
32. Chano T, Ikebuchi K, Ochi Y, Tameno H, Tomita Y, Jin Y et al. RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. PLoS One 2010; 5: e11404.
33. Morin PJ. Beta-catenin signaling and cancer. Bioessays 1999; 21: 1021-1030.
34. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL et al. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 2001; 7: 927-936.
35. Bonvini P, Hwang SG, El-Gamil M, Robbins P, Kim JS, Trepel J et al. Nuclear beta-catenin displays GSK-3beta-and APC-independent proteasome sensitivity in melanoma cells. Biochim Biophys Acta 2000; 1495: 308-318.
36. Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lym-phoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 2001; 153: 1161-1174.
37. Xiao JH, Ghosn C, Hinchman C, Forbes C, Wang J, Snider N et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem 2003; 278: 29954-29962.
38. Wei H, Gan B, Wu X, Guan JL. Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models. J Biol Chem 2009; 284: 6004-6013.
39. Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI et al. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol 2008; 10: 1208-1216.
40. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
41. Jang ER, Choi JD, Lee JS. Acetyltransferase p300 regulates NBS1-mediated DNA damage response. FEBS Lett 2011; 585: 47-52.
42. Park MA, Seok YJ, Jeong G, Lee JS. SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res 2008; 36: 263-283.
43. Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000; 404: 201-204.